Majority (84%) of children clinically diagnosed with NAFLD meet criteria for metabolic dysfunction-associated steatotic liver disease (MASLD).
Approximately 16% of pediatric patients are reclassified due to alcohol use below adult thresholds (Met-ALD) or drug-induced liver injury.
Adolescents have a higher prevalence (5.4%) of Met-ALD, underscoring the importance of detailed alcohol consumption assessment in this group.
A systematic diagnostic approach incorporating metabolic risk factors, alcohol exposure, and medication history is critical for accurate diagnosis and management of pediatric steatotic liver diseases.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
